Clinical trial
Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion
NCT00794014 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- February 29, 2012
- Enrollment
- 258 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.